To further confirm the role of the CCL4L2/VSIR axis in gut dysbiosis‐derived IBD in vivo, selected bacterial transplantation (SBT) was performed in C57BL/6 mice (Figure 7A). This evidence concerns the gene CCL4L2 and inflammatory bowel disease.